Non-invasive
prenatal testing (NIPT) offers women safer and more reliable options for
prenatal screening compared to traditional screening methods. It analyzes
cell-free DNA from a simple blood draw of the mother to screen for common
genetic conditions like Down syndrome with high accuracy. The rising cases of
pregnancies affected by chromosomal abnormalities have boosted the demand for
NIPT across North Africa.
The North
Africa Non-Invasive Prenatal Testing Market is estimated to be valued at US$
3805.83 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
The increased adoption of NIPT is mainly driven by the rising prevalence of
chromosomal abnormalities during pregnancies across North Africa. According to
WHO, the prevalence of Down syndrome is around 1 in 1000 live births in North
Africa. NIPT helps identify such abnormalities at an early stage, allowing
parents to make informed decisions. It has high detection rates of over 99% for
common trisomies like trisomy 21, reducing the need for invasive diagnostic
tests. As such abnormalities are becoming more common, NIPT is gaining
popularity as the primary prenatal screening method in the region.
Segment Analysis
The North Africa non-invasive prenatal testing (NIPT)
market is dominating by the screening and diagnostic tests segment. This
segment accounts for the major share due to high adoption of advanced screening
and diagnostic tests for prenatal genetic screening. Rapid technological
advancements facilitating the availability of improved screening and diagnostic
tests for prenatal screening has further driven the growth of this segment.
Key Takeaways
The
North
Africa non-invasive prenatal testing market size is expected to witness
high growth during the forecast period. The North Africa Non-Invasive Prenatal
Testing Market is estimated to be valued at US$ 3805.83 Bn in 2024 and is
expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.
The
Egypt non-invasive prenatal testing market is expected to witness the fastest
growth over the forecast period. This is attributed to growing awareness about
prenatal testing and availability of advanced healthcare facilities in the
country.
Key
players operating in the North Africa non-invasive prenatal testing (NIPT)
market are Enraf-Nonius B.V., DJO Global, EMS Physio Ltd., Dynatronics
Corporation, A. Algeo Limited, BTL Industries, Inc., HMS Medical Systems,
Whitehall Manufacturing, Patterson Companies, Inc., and Isokinetics, Inc.
Comments
Post a Comment